sciencebriefs
11:14in productionCh. 1 · The Cori Cycle/ 11:14 · ceiling 15 min
Medicine · Genetics

Gerty Cori

1896–1957

Enzyme defects cause genetic disease — and this was proven, not hypothesised.

Gerty Cori’s work established the Cori cycle, identified glucose 1-phosphate as a reversible metabolic intermediate, characterised phosphorylase, and proved enzyme defects cause human genetic disease — all through direct biochemical observation in frog and human tissue.

MedicineGeneticsDiseaseGeneticsBiodiversityDisease across the network →
Chapters & takeaways4
  1. 1:12
    The Cori Cycle

    Glycogen breaks down to lactic acid in muscle, then resynthesises elsewhere as energy.

  2. 3:03
    The Cori Ester

    Glucose 1-phosphate is the first chemical step in glycogen breakdown — and the last in its storage.

  3. 5:02
    The First Metabolic Enzyme

    Phosphorylase makes glucose 1-phosphate — the first enzyme assigned to a defined step in glycogen metabolism.

  4. 6:57
    Enzymes Cause Disease

    Four glycogen storage diseases were traced to distinct enzyme failures — proving enzyme defects cause human genetic disease.

Worth your time?

Yes. Study the whole thing.

4.5/ 5
What works
  • mechanistic explanation of glycogen metabolism
  • first enzyme–disease causal link in humans
  • reversible biochemical step with defined enzyme
What does not
  • proof
  • consensus
  • replication
  • therapeutic application
Study it if
  • clinicians
  • biochemists
  • genetic counsellors
Skip it if
  • data scientists
  • astronomers
  • climate modellers
The written brief1 min read

What the work claims

Glycogen metabolism proceeds via a defined biochemical cycle involving lactic acid and reversible glucose 1-phosphate formation. Enzyme defects directly cause inherited human disease.

How it was done

They studied frog muscle tissue to identify an intermediate compound in glycogen breakdown. They isolated glucose 1-phosphate, determined its structure, identified phosphorylase as the enzyme that forms it, and demonstrated its reversibility. Gerty Cori examined human glycogen storage diseases, linking clinical phenotypes to specific enzymatic defects.

What holds up

The Cori cycle — glycogen → lactic acid in muscle, then resynthesis in liver — is established. Glucose 1-phosphate is confirmed as a reversible intermediate. Phosphorylase is identified as its catalysing enzyme. At least four glycogen storage disease forms are linked to specific enzymatic defects. Enzyme deficiency as cause of human genetic disease is demonstrated.

What does not

The sources do not report proof of causality beyond enzyme–disease linkage in glycogen storage diseases. They do not describe molecular mechanisms of enzyme defects, genetic inheritance patterns, or therapeutic interventions. No replication, consensus, or refutation is mentioned.

Why it matters beyond the lab

It established the first direct causal link between a human genetic disease and a specific enzyme defect — founding the field of inborn errors of metabolism. It made glycogen metabolism experimentally tractable, enabling later work on insulin signalling, diabetes therapeutics, and exercise physiology.

Is it worth your time

Yes. It redefined how metabolism is understood mechanistically — not as a black box but as a sequence of defined chemical steps with identifiable enzymes and intermediates. The work remains foundational for endocrinology, metabolic genetics, and pharmacology.

Same field · Medicine4 of 84
13:00
Human microbiomeThe human microbiome is the community of bacteria, archaea, fungi and viruses that inhabit the human body, and DNA sequencing rather than laboratory culturing has let researchers count and classify it properly for the first time. The Human Microbiome Project's 2012 results replaced rough estimates of microbial abundance with directly measured ones and confirmed genuine roles for gut bacteria in digestion and immune development. What the data has not done is turn most of the microbiome's associations with disease into demonstrated causes.
13:00
T helper cellT helper cells coordinate adaptive immunity by releasing cytokines that instruct B cells, cytotoxic T cells and other immune components, rather than attacking pathogens directly, and they are activated when their receptor and CD4 co-receptor together recognise an antigen presented on MHC class II. The brief covers the layered activation process, the differentiation of helper cells into subtypes such as Th1, Th2 and Th17 with distinct cytokine profiles, and the ongoing debate over how rigid that subtype model really is. It also follows CD4 itself, the co-receptor these cells are named for, into its second and more consequential role as the molecule HIV binds to enter cells, and why a falling CD4 count has long served as a marker of immune collapse in HIV infection.
9:26
Human Microbiome ProjectThe Human Microbiome Project built the first large-scale reference database of human-associated microbes using culture-independent sequencing. It mapped microbial presence across body sites in healthy volunteers. It delivered essential infrastructure — not explanations, not cures, not definitions of health. Its value is in what it enables downstream, not what it concluded.
11:14
Henrietta Lacks1920–1951HeLa was not a discovery of mechanism but of behaviour: human cells that would not die in culture. That single observation — made on cells taken without consent — unlocked decades of reproducible experiment. Its legacy is dual: methodological necessity and ethical rupture.
Up next in Science

Milankovitch cycles

· 13:00

Milutin Milanković worked out how slow wobbles and stretches in Earth's orbit change sunlight at high latitudes, and ice cores confirm the pattern, but the dominant cycle length still does not match his prediction.

Play nextBack to Medicine
13:00